Knight Therapeutics (TSX:GUD) Q3 2026 Earnings Call
Knight Therapeutics (TSX:GUD) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Knight Therapeutics, Inc. (TSX:GUD)
- Period
- Q3 2026 earnings call
- Date
- Thu, Nov 5, 2026, 8:30 AM ET
On 6ix: 6ix.com/event/knight-therapeutics-inc-gud-q3-2026-earnings-call
Latest news releases
- TSX:GUD — Notice of Knight Therapeutics' Third Quarter 2026 Results Conference Call · Thu, Oct 29, 2026
- TSX:GUD — Knight Therapeutics Announces Regulatory Approval of NIKTIMVO® in Brazil · Tue, Oct 6, 2026